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Exposure of rhodopsin to bright white light can induce photoreceptor cell damage and
degeneration. However, a comprehensive understanding of the mechanisms underlying
light-induced retinopathy remains elusive. In this study, we performed comparative
transcriptome analysis of three rodent models of light-induced retinopathy, and we
identified 37 genes that are dysregulated in all three models. Gene ontology analysis
revealed that this gene set is significantly associated with a cytokine signaling axis
composed of signal transducer and activator of transcription 1 and 3 (STAT1/3),
interleukin 6 signal transducer (IL6ST), and oncostatinM receptor (OSMR). Furthermore,
the analysis suggested that the histone acetyltransferase EP300 may be a key upstream
regulator of the STAT1/3–IL6ST/OSMR axis. To examine the role of EP300 directly, we
developed a larval zebrafish model of light-induced retinopathy. Using this model, we
demonstrated that pharmacological inhibition of EP300 significantly increased retinal cell
apoptosis, decreased photoreceptor cell outer segments, and increased proliferation of
putative Müller cells upon exposure to intense light. These results suggest that EP300
may protect photoreceptor cells from light-induced damage and that activation of EP300
may be a novel therapeutic approach for the treatment of retinal degenerative diseases.
Keywords: light-induced retinopathy, EP300, STAT3, apoptosis, comparative transcriptome analysis, zebrafish,
systems pharmacology
INTRODUCTION
Retinal photoreceptor cells are uniquely adapted to function over a wide range of ambient light
conditions. However, in most species, prolonged exposure to intense visible light can lead to
photoreceptor cell damage (reviewed in Wenzel et al., 2005; Organisciak and Vaughan, 2010;
Chen et al., 2016). Light-induced retinal damage serves as a model to study human retinal
degeneration arising from environmental insult, aging, and genetic disease. Accordingly, animal
models of light-induced retinopathy have been used successfully to develop therapeutic approaches
for retinal degenerative diseases (Tsuruma et al., 2014; Shimazawa et al., 2015). While many of the
light-induced retinopathy models share similar mechanisms, there are also significant differences
(reviewed in Organisciak and Vaughan, 2010). For example, inhibition of the transcription factor
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(TF) activator protein-1 protects against light damage in mice
(Wenzel et al., 2001) but not in T4R rhodopsin mutant dogs
(Gu et al., 2009). Similarly, exposure to intense white light causes
degeneration of retinal pigment epithelial cells in rats but not in
mice (Remé et al., 1998). These findings suggest that there may
be shared and unique pathways of light-induced retinal cell death
in the various models.
Comparative transcriptome analysis has been used
successfully to identify common and divergent genomic
responses in a disease entity caused by various etiologies in
different species (Nishimura et al., 2007, 2015b; Oka et al.,
2010). Here, we sought to identify genes that are dysregulated
in multiple models of light-induced retinopathy and might
therefore, be exploited as novel therapeutic targets. We
compared the transcriptomes of three rodent models of light-
induced retinopathy (Rattner and Nathans, 2005; Natoli et al.,
2010; Hadziahmetovic et al., 2012) and identified 37 genes
that were differentially expressed in all three models. We also
demonstrated that (i) a signaling axis composed of signal
transducer and activator of transcription 1 and 3 (STAT1/3),
interleukin 6 signal transducer (IL6ST), and oncostatinM
receptor (STAT1/3–IL6ST/OSMR), which is involved in the
neuroprotective role of IL-6 (Jung et al., 2011), plays a key role
in light-induced retinopathy, (ii) the histone acetyltransferase
(HAT) EP300 is a key upstream regulator of the STAT1/3–
IL6ST/OSMR axis, and (iii) EP300 plays a protective role
in the larval zebrafish model of light-induced retinopathy,
suggesting that EP300 may be a novel therapeutic target for
retinal degenerative diseases.
MATERIALS AND METHODS
Ethics Statement
This study was carried out in strict accordance with Japanese law,
including the Human Treatment and Management of Animals
Act (2014), Standards Relating to the Care and Management of
Laboratory Animals and Relief of Pain (2013), and the Guidelines
for Proper Conduct of Animal Experiments (Science Council
of Japan, 2006). All experiments were performed on animals
under 2-phenoxyethanol anesthesia, and all efforts were made to
minimize animal suffering.
Compounds
The HAT inhibitor C646 (Bowers et al., 2010), phenylthiourea,
and 5-bromo-2-deoxyuridine (BrdU) were purchased from
Sigma (St. Louis, MO, USA). Stock solutions of C646
and phenylthiourea were prepared in dimethyl sulfoxide
(DMSO; Nacalai Tesque, Kyoto, Japan). BrdU was dissolved
in 0.3× Danieau’s solution [19.3mM NaCl, 0.23mM KCl,
0.13mM MgSO4, 0.2mM Ca(NO3)2, 1.7mM HEPES, pH 7.2].
2-Phenoxyethanol was obtained from Wako Chemicals (Osaka,
Japan).
Comparative Transcriptome Analysis
To identify genes that are differentially expressed in multiple
rodent models of light-induced retinopathy, we analyzed
three transcriptome datasets deposited in the Gene Expression
Omnibus (GEO; Barrett et al., 2009), designated GSE10528
(Rattner and Nathans, 2005), GSE22818 (Natoli et al., 2010),
and GSE37773 (Hadziahmetovic et al., 2012). The raw data were
normalized using the packages “affy” (Gautier et al., 2004) for
GSE10528 and “oligo” (Carvalho et al., 2007) for GSE22818
and GSE37773 in Bioconductor (Gentleman et al., 2004). Probes
with reliable signals were selected and subjected to RankProd
(Breitling et al., 2004) analysis to identify differentially expressed
genes (DEGs) in each model using a false discovery rate of 10% as
the threshold. The gene symbols of the DEGs were converted to
the human orthologs using Life Science Knowledge Bank (World
Fusion, Tokyo, Japan), and UniProt IDs were added using the
ID mapping tool of UniProt (UniProtConsortium, 2015). Venn
diagrams showing the number of shared and unique DEGs in the
three models were drawn using PINA4MS (Cowley et al., 2012)
in Cytoscape (Shannon et al., 2003).
We identified functional networks significantly related to the
37 DEGs common to the three rodent models of light-induced
retinopathy by using JEPETTO (Winterhalter et al., 2014) as
the integrative analytical tool, with STRING (Jensen et al., 2009)
for the protein interaction network analyses and Gene Ontology
(Gene Ontology Consortium, 2015), InterPro (Mitchell et al.,
2015), or BioCarta (Nishimura, 2001) for the functional analyses.
To identify TFs potentially regulating the 37 common DEGs,
we used iRegulon (Janky et al., 2014), which has been used
successfully to identify important TFs from gene lists (Nishimura
et al., 2015b; Sasagawa et al., 2016). The predicted transcriptional
regulators with normalized enrichment scores (NES) >3 are
shown in Table S2.
Zebrafish
We used an albino line (Kelsh et al., 1996) obtained from the
Max Planck Institute for Developmental Biology (Tübingen,
Germany). Zebrafish were bred and maintained according to
previously described methods (Westerfield, 2007; Nishimura
et al., 2016). Briefly, zebrafish were raised at 28.5 ± 0.5◦C
with a 14 h/10 h light/dark cycle. Embryos were obtained and
cultured in 0.3×Danieau’s solution until 6 days post-fertilization
(dpf). For modeling light-induced retinopathy, zebrafish
were cultured in 0.3× Danieau’s solution containing 200µM
phenylthiourea.
A Larval Zebrafish Model of Light-Induced
Retinopathy
Zebrafish at 3 dpf were wrapped in aluminum foil and shielded
from light for 48 h. On day 5 dpf, the animals were transferred to
12-well plates (7 larvae/3ml medium/well) and incubated under
normal conditions (28◦C, 14 h [7 a.m.–10 p.m.] dim light/10 h
dark) or placed in a custom-made chamber (Hayashi Factory,
Kyoto, Japan) to induce retinopathy (Figure S3). The chamber
was 47 × 47 × 27 cm in width, length, and height, respectively,
and was equipped with six fluorescent lamps (FL10ECW,
Panasonic, Osaka, Japan) housed in the lid. Lamp specifications
were 33 cm length, 520 lumen, 7200 kelvin, and emission peaks
at 450, 540, and 610 nm. The inner walls of the chamber were
lined with mirrors to expose the zebrafish to light from all
directions. The multi-well plates were placed on a water-cooled
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plate within the chamber to maintain the animals at 27◦C during
light exposure.
TUNEL Staining
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) was performed using an ApopTag Fluorescein In situ
Apoptosis Detection Kit (Millipore, Billerica, MA, USA)
according to the manufacturer’s protocol. Briefly, zebrafish were
exposed for 24 h to intense light (13,000 lux) or normal light
conditions (14 h/10 h light/dark cycle) in medium with or
without 2µM C646 and then fixed in 4% paraformaldehyde
in phosphate-buffered saline (PBS; Nacalai Tesque) at 4◦C
overnight. Animals were washed with PBS containing 0.1%
Tween 20 (PBST), incubated in water containing 3% H2O2 and
1% KOH at room temperature for 30min, washed again with
PBST, and incubated in 100% methanol at −30◦C overnight.
Zebrafish were rehydrated, treated with proteinase K (40µg/ml)
at 37◦C for 1 h, washed with PBST, incubated in equilibration
buffer at 37◦C for 1 h, and then incubated in working solution
containing TdT enzyme and digoxigenin-labeled dNTP at
37◦C for 1 h. The animals were then washed and treated
with fluorescein-labeled anti-digoxigenin IgG at 4◦C overnight.
Finally, zebrafish were washed once more with PBST and imaged
with a SMZ25 stereomicroscope (Nikon, Tokyo, Japan) equipped
with a GFP-BP filter. Quantitative analysis of the fluorescent
images was performed using Volocity software (PerkinElmer,
Waltham, MA, USA). The threshold fluorescence intensity for
defining apoptotic areas of the retina was set at five standard
deviations above the mean fluorescence intensity of the whole
field of view.
Whole-Mount Fluorescent
Immunohistochemistry
For the assessment of photoreceptor cells, zebrafish were exposed
to intense or normal light conditions with or without 2µM
C646 as described above, and then fixed in 4% paraformaldehyde
in PBS at 4◦C overnight. Zebrafish were then washed with
PBST, incubated in water containing 3% H2O2 and 1% KOH
at room temperature for 30min, washed again with PBST,
and incubated in 100% methanol at −30◦C overnight. After
rehydration, zebrafish were treated with proteinase K (40µg/ml)
at 28◦C for 30min, washed with PBST, and then incubated in
Blocking One Histo (Nacalai Tesque) at 4◦C overnight. Animals
were washed again with PBST and incubated in Can Get Signal
Immunostain B solution (Toyobo, Osaka, Japan) containing anti-
Zpr3 antibody (1:50, ZIRC, Eugene, OR, USA) at 4◦C overnight.
Zebrafish were washed with PBST and incubated in Can Get
Signal Immunostain B solution (Toyobo) containing Alexa Fluor
488-conjugated anti-mouse IgG (1:500, Invitrogen, Carlsbad,
CA) at 4◦C overnight. After a final wash with PBST, animals
were imaged with a SMZ25 stereomicroscope equipped with a
GFP-BP filter. Quantitative analysis of the fluorescent images was
performed using Volocity software. The threshold fluorescence
intensity for identifying photoreceptor cell outer segments was
set at four standard deviations above the mean fluorescence
intensity of the whole field of view.
Retinal cell proliferation was measured as described above for
the assessment of retinal cells, with the following modifications.
Zebrafish were exposed to intense or normal light conditions
in 0.3× Danieau’s solution containing 10mM BrdU with or
without 2µM C646, and then fixed, dehydrated, and rehydrated
as described above. After rehydration, animals were treated
with proteinase K (40µg/ml) at 37◦C for 60min, washed with
PBST, and then incubated in Blocking One Histo (Nacalai
Tesque) at 4◦C overnight. Animals were washed again with
PBST and incubated in Can Get Signal Immunostain B solution
(Toyobo) containing anti-BrdU antibody (1:100, Sigma) at 4◦C
overnight. Zebrafish were then processed as described above
except the Alexa Fluor 488-conjugated anti-mouse IgG was used
at 1:200 dilution. Finally, the animals were imaged with a SMZ25
stereomicroscope equipped with a GFP-BP filter. Quantitative
analysis of the fluorescent images was performed using Volocity
software. The threshold fluorescence intensity for BrdUwas set at
three standard deviations above the mean fluorescence intensity
of the whole field of view.
Statistical Analysis
Statistical analysis was performed using Prism 6 (GraphPad,
La Jolla, CA, USA). For the assessment of apoptosis (TUNEL
staining) and photoreceptor cell outer segments, group means
were compared by analysis of variance followed by Tukey’s
multiple comparisons test. For the assessment of BrdU-positive
cells, group means were compared by the Kruskal–Wallis test
followed by Dunn’s multiple comparisons test. Data are shown
as the mean± standard error (SEM).
RESULTS
Identification of DEGs Common to the
Three Rodent Models of Light-Induced
Retinopathy
To identify genes that are differentially expressed in multiple
light-induced retinopathy models, we downloaded three
transcriptome datasets from studies examining the retinas of
rodents exposed to different light conditions. GSE10528 was
from albino BALB/c mice 24 h after exposure to 6000 lux for
6 h (Rattner and Nathans, 2005), GSE22818 was from albino
Sprague Dawley rats after exposure to 1000 lux for 24 h (Natoli
et al., 2010), and GSE37773 was from albino BALB/c mice 4 h
after exposure to 10,000 lux for 18 h (Hadziahmetovic et al.,
2012). Using a false discovery rate of 10% as the threshold, we
identified 261, 256, and 788 genes in GSE10528, GSE22818, and
GSE37773, respectively, that were differentially expressed in
animals exposed to intense light compared with normal light
conditions (Table S1). Among the 39 DEGs that overlapped
in the three light-induced retinopathy models (Figure 1), the
change in expression was the same for 37 DEGs (Table 1),
suggesting that they may be related to the pathophysiology of
light-induced retinopathy.
Identification of STAT1/3–IL6ST/OSMR As
a Key Signaling Pathway in Light-Induced
Retinopathy
We next investigated which functional networks were
significantly associated with the 37 common DEGs using
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FIGURE 1 | Venn diagram of differentially expressed genes in the three
rodent models of light-induced retinopathy. Transcriptome datasets from
three different rodent models of light-induced retinopathy (GSE10528,
GSE22818, and GSE37773) were downloaded from a public database (GEO).
Genes that were differentially expressed in the light-induced retinopathy vs.
control groups were identified using a false discovery rate of 10% as the
threshold. The number of differentially expressed genes in each transcriptome
dataset and the overlap between datasets are shown.
the JEPETTO analytical plugin for Cytoscape (Winterhalter
et al., 2014). JEPETTO performs integrated analyses using
protein interaction networks such as STRING (Jensen et al.,
2009) and various databases such as Gene Ontology (Gene
Ontology Consortium, 2015), InterPro (Mitchell et al., 2015),
and BioCarta (Nishimura, 2001) to find functional networks
significantly related to a given gene list. Using JEPETTO with
InterPro, we found that “STAT transcription factor, coiled coil”
was significantly associated with the 37 common DEGs (XD
score 0.56 and q-value 1.7 × 10−1, Figure 2). Among the 12
genes included in the “STAT transcription factor, coiled coil”
network, 7 genes (STAT1, STAT3, IL6ST, OSMR, JUN, FOS, and
IRF9) were significantly upregulated in the three rodent models
of light-induced retinopathy. STAT1 and STAT3 can form
homodimers or heterodimers (reviewed in Kisseleva et al., 2002).
A coiled coil domain important for protein–protein interactions
is conserved in all members of the STAT family (reviewed
in Reich, 2013). Interleukin 6 signal transducer (IL6ST), also
known as GP130, can form heterodimers with the oncostatinM
receptor (OSMR; Hermanns et al., 1999). Activation of STAT3
increases transcription of IL6ST (O’Brien and Manolagas, 1997)
and OSMR (Traber et al., 2015) and, in turn, activation of
IL6ST/OSMR leads to STAT1/3 activation (Dreuw et al., 2004).
These findings suggest that STAT1/3 and IL6ST/OSMR may
form a positive feedback loop. Using JEPETTO in combination
with Gene Ontology and BioCarta, we found that “IL 6 signaling
pathway” (XD score 0.70 and q-value 5.8× 10−4, Figure S1) and
“growth factor binding” (XD score 0.50 and q-value 2.6 × 10−2,
Figure S2), respectively, were significantly associated with the 37
common DEGs. STAT1, STAT3, IL6ST, OSMR, JUN, FOS, and
IRF9 are represented in the “STAT transcription factor, coiled
coil,” “IL 6 signaling pathway,” and “growth factor binding”
networks. These results suggest that STAT1/3–IL6ST/OSMR
may be a key signaling pathway in the pathophysiology of
light-induced retinopathy.
Identification of EP300 As a Key
Transcription Factor in Light-Induced
Retinopathy
We hypothesized that the 37 DEGs common to the three
rodent models of light-induced retinopathy might be regulated
by specific TFs. To test this, we analyzed the gene sets using
iRegulon, which exploits the fact that genes co-regulated by the
same TF contain common TF binding sites and uses gene sets
derived from ENCODE ChIP-seq data (Gerstein et al., 2012;
Janky et al., 2014). Using iRegulon, we identified six TFs with
significant NES (>3), suggesting that they regulate the expression
of common DEGs (Table S2). EP300, STAT1, and STAT3 were
the first, second, and third ranked TFs by significance. iRegulon
identified 28 genes (Figure 3A), 6 genes (Figure 3B), and 20
genes (Figure 3C) as potential transcriptional targets of EP300,
STAT1, and STAT3, respectively. The union of the EP300, STAT1,
and STAT3 networks and their potential transcriptional targets
is shown in Figure 3D. Of the potential targets, 17 genes,
including STAT1, STAT3, IL6ST, and OSMR, were targets of
EP300 and either STAT1 or STAT3. These results suggest that
EP300 and STAT1/3 may regulate the expression of the 16 genes
cooperatively and that EP300 may be a key TF in light-induced
retinopathy.
Inhibition of EP300 Increases Apoptosis in
the Zebrafish Model of Light-Induced
Retinopathy
To examine the function of EP300 in light-induced retinopathy,
we developed a novel model using larval zebrafish (Figures S3
and Figure 4A). Larval zebrafish were first shielded from light
for 48 h between 3 and 5 dpf and then exposed to intense light
(13,000 lux for 24 h) or housed under normal conditions (14 h
250 lux/10 h dark) in the absence or presence of C646, a specific
inhibitor of EP300 (Bowers et al., 2010). At the end of the 24 h
incubation, retinal apoptosis was examined by TUNEL staining.
The retinas of zebrafish exposed to intense light had significantly
higher apoptosis levels than the retinas of zebrafish housed under
normal conditions (Figures 4B,C). Moreover, C646 treatment
further increased the level of apoptosis in the retinas of zebrafish
exposed to intense light, whereas it had no effect on zebrafish
housed under normal light conditions (Figure 4C). To exclude
the possibility that C646 might induce non-specific cell death
following light exposure, we measured apoptosis in the forebrain.
However, we found no significant difference in the apoptotic
signals between the forebrains of zebrafish exposed to intense
light with and without C646 treatment (data not shown). These
results suggest that activated EP300 may protect the retina by
reducing apoptosis during intense light exposure.
Inhibition of EP300 Increases Loss of
Photoreceptor Cell Outer Segments in the
Zebrafish Model of Light-Induced
Retinopathy
To further investigate the role of EP300 in retinal protection,
we performed whole-mount immunohistochemical staining of
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TABLE 1 | DEGs common to the three rodent models of light-induced retinopathy.
Symbol Name GSE10528 GSE22818 GSE37773
log(light/cnt) FDR log(light/cnt) FDR log(light/cnt) FDR
A2M Alpha-2-macroglobulin 2.39 0.00 0.83 0.06 2.70 0.00
ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif 1 1.48 0.01 1.40 0.01 1.35 0.00
AHR Aryl hydrocarbon receptor 1.01 0.07 1.84 0.00 1.32 0.00
AQP1 Aquaporin 1 −1.13 0.01 −1.32 0.00 −0.74 0.02
CD44 CD44 molecule 2.34 0.00 1.26 0.01 1.73 0.00
CP Ceruloplasmin 2.14 0.00 1.25 0.02 1.95 0.00
DUSP6 Dual specificity phosphatase 6 1.69 0.00 0.96 0.04 0.73 0.02
EBPL Emopamil binding protein-like −0.92 0.04 −1.18 0.00 −0.96 0.00
EDN2 Endothelin 2 3.69 0.00 0.99 0.03 0.76 0.02
FOS FBJ murine osteosarcoma viral oncogene homolog 1.14 0.08 1.28 0.01 1.00 0.00
IFITM2 Interferon induced transmembrane protein 2 1.31 0.01 1.64 0.01 2.45 0.00
IL6ST Interleukin 6 signal transducer 1.15 0.03 1.10 0.02 1.21 0.00
IPO5 Importin 5 1.25 0.01 0.98 0.03 1.13 0.00
IRF9 Interferon regulatory factor 9 1.86 0.00 2.35 0.00 2.30 0.00
ITGB1 Integrin, beta 1 1.00 0.07 0.76 0.10 0.59 0.05
JUN Jun proto-oncogene 1.57 0.00 2.04 0.00 1.42 0.00
LGALS3 Lectin, galactoside-binding, soluble, 3 3.14 0.00 1.30 0.02 0.80 0.01
LITAF Lipopolysaccharide-induced TNF factor 0.97 0.08 1.91 0.00 0.68 0.03
MSN Moesin 2.19 0.00 1.03 0.04 1.97 0.00
NRL Neural retina leucine zipper −1.04 0.02 −1.12 0.01 −0.81 0.01
OPTN Optineurin −0.91 0.04 −0.96 0.02 −0.69 0.03
OSMR OncostatinM receptor 3.04 0.00 2.59 0.00 2.61 0.00
PDPN Podoplanin 2.78 0.00 1.99 0.00 1.79 0.00
PITPNM3 PITPNM family member 3 −1.37 0.00 −0.84 0.08 −0.71 0.02
PROS1 Protein S (alpha) 0.96 0.09 1.06 0.02 1.72 0.00
RDH10 retinol dehydrogenase 10 (all-trans) 1.00 0.07 1.58 0.00 0.50 0.10
REEP6 Receptor accessory protein 6 −1.23 0.01 −1.70 0.00 −1.30 0.00
S100A10 S100 calcium binding protein A10 2.44 0.00 0.91 0.06 2.03 0.00
S100A6 S100 calcium binding protein A6 2.45 0.00 1.16 0.03 3.62 0.00
SLC14A1 Solute carrier family 14, member 1 2.17 0.00 1.41 0.01 2.57 0.00
SLC24A1 Solute carrier family 24 member 1 −0.85 0.06 −0.98 0.03 −0.65 0.04
STAT1 Signal transducer and activator of transcription 1, 91kDa 2.00 0.00 1.60 0. 01 2.17 0.00
STAT3 Signal transducer and activator of transcription 3 1.92 0.00 2.03 0.00 1.96 0.00
SUSD3 Sushi domain containing 3 −1.06 0.02 −1.18 0.00 −0.74 0.02
TAGLN2 Transgelin 2 0.98 0.09 0.96 0.05 1.03 0.00
TARS Threonyl-tRNA synthetase 1.06 0.05 1.22 0.01 0.66 0.03
TRIM25 Tripartite motif containing 25 1.01 0.07 0.97 0.04 1.53 0.00
The changes of gene expression increased and decreased in light-induced retinopathy are shown in red and blue, respectively.
larval zebrafish with light-induced retinopathy (Figure 5A)
using anti-Zpr3 antibody, which detects both rod and cone
photoreceptor cell outer segments (Yin et al., 2012). As shown
in Figure 5B, the fluorescent signal from the photoreceptor cell
outer segments, especially in the area between the rim and the
lens, was decreased in zebrafish exposed to intense light in the
presence of C646. Quantitative analysis of the fluorescent signal
revealed a significant reduction in the area of photoreceptor
cell outer segments in zebrafish exposed to intense light in
the presence of C646 compared with zebrafish housed under
normal conditions (Figure 5C). The retina diameters were not
significantly different among the four groups (data not shown).
These results support a role for EP300 in protecting the retina
from light-induced damage, at least in zebrafish.
Inhibition of EP300 Increases BrdU
Incorporation in Putative Müller Cells in the
Zebrafish Model of Light-Induced
Retinopathy
Following retinal injury, zebrafish Müller glia proliferate and
differentiate into the retinal cell types lost through injury
Frontiers in Pharmacology | www.frontiersin.org 5 May 2016 | Volume 7 | Article 126
Kawase et al. EP300’s Role in Light-Induced Retinopathy
FIGURE 2 | Identification of “STAT transcription factor, coiled coil” as
the domain most significantly associated with the DEGs common to
the three rodent models of light-induced retinopathy. (A) Scatter plot of
domains in InterPro based on the network-based association score (XD score)
and the significance of overlap (q-value) using the 37 common DEGs as the
input in JEPETTO. The most significant domain was “STAT transcription factor,
coiled coil.” (B) The “STAT transcription factor, coiled coil” network identified
by JEPETTO. The seven genes with increased expression in the light-induced
retinopathy models are shown in red.
(Lenkowski and Raymond, 2014). To determine whether Müller
cells proliferate in zebrafish with light-induced retinopathy,
zebrafish were immersed in medium containing BrdU with
or without C646 and/or exposed to intense light for 1 day
(Figure 6A), after which, whole-mount immunohistochemical
staining with anti-BrdU antibody was performed. As shown in
Figures 6B,C, there was a significant increase in the appearance
of BrdU-positive cells with an elongated morphology, consistent
with the morphology of proliferating Müller cells (Yurco and
Cameron, 2005), in zebrafish treated with C646 and exposed to
intense light. These results suggest that inhibition of EP300 may
increase retinal injury in the zebrafish model of light-induced
retinopathy, thereby stimulating the proliferation of Müller glia.
DISCUSSION
The results of this study suggest that (i) the STAT1/3–
IL6ST/OSMR axis is a key signaling pathway in three rodent
models of light-induced retinopathy, (ii) EP300 is a key upstream
regulator of the STAT1/3–IL6ST/OSMR axis, and (iii) EP300
plays a protective role in a larval zebrafish model of light-induced
retinopathy.
The STAT1/3–IL6ST/OSMR Axis Is a Key
Signaling Pathway in Light-Induced
Retinopathy
We identified 37 genes differentially regulated in the three rodent
models of light-induced retinopathy, and found significant
enrichment of these genes in “STAT transcription factor, coiled
coil,” “IL 6 signaling pathway,” and “growth factor binding”
networks. STAT1, STAT3, IL6ST, and OSMR were represented in
all three networks and the expression of these genes was increased
in the three rodent models studied here.
Previous work has demonstrated that the expression of STAT1
and STAT3 is increased in light-induced retinopathy (Samardzija
et al., 2006) and that the increase in STAT3 is not observed
in leukemia inhibitory factor (LIF) null mice (Bürgi et al.,
2009). In the retina of BALB/c mice, expression of LIF, which
is a member of the IL-6 family (Heinrich et al., 2003), is
markedly increased by light exposure, peaking at 6 to 12 h after
exposure (Samardzija et al., 2006). These findings suggest that
the increased expression of STAT1 and STAT3 observed in the
three light-induced retinopathy models examined here may be
mediated by LIF. STAT1 and STAT3 can bind to the promoter
of IL6ST as homodimers or heterodimers and positively regulate
its transcription (O’Brien and Manolagas, 1997). Activation of
STAT3 also increases transcription of OSMR (Traber et al.,
2015). Therefore, the retinopathy-associated increase in IL6ST
and OSMR detected here may be a result of STAT1/3-mediated
transcriptional activation.
IL6ST and OSMR have also been shown to form heterodimers
(Hermanns et al., 1999), and activation of such heterodimers
leads to STAT1/3 activation (Dreuw et al., 2004). Given
that STAT1, STAT3, IL6ST, and OSMR are all differentially
upregulated in the models studied here, these reports are
consistent with the hypothesis that the STAT1/3–IL6ST/OSMR
axis is activated in light-induced retinopathy. Knockout
of IL6ST increases photoreceptor cell death not only in a
light-induced retinal damage model (Ueki et al., 2009) but
also in other photoreceptor degeneration models such as
retinitis pigmentosa and age-related macular degeneration
(Rhee et al., 2013). Photoreceptor-specific deletion of STAT3
accelerates photoreceptor degeneration, whereas the expression
of dominant active STAT3 improves photoreceptor survival
in two models of retinitis pigmentosa (Jiang et al., 2014).
Collectively, these findings are consistent with the possibility that
STAT1/3–IL6ST/OSMR axis may be activated in light-induced
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FIGURE 3 | Identification of EP300, STAT1, and STAT3 as the key transcription factors potentially regulating the DEGs common to the three rodent
models of light-induced retinopathy. (A–C) The DEGs common to the three models and potentially regulated by EP300 (A), STAT1 (B), and STAT3 (C). (D) The
union of the EP300, STAT1, and STAT3 networks and their potential targets.
retinopathy as an endogenous anti-apoptotic signaling
pathway.
EP300 Is a Key Upstream Regulator of the
STAT1/3–IL6ST/OSMR Axis
Our study identified 16 genes, including STAT1, STAT3, IL6ST,
and OSMR, as potential transcriptional targets of EP300 and
either STAT1 or STAT3, suggesting that EP300 and STAT1/3
may act cooperatively to regulate expression of the 16 genes in
light-induced retinopathy.
EP300 is a transcriptional cofactor with intrinsic
acetyltransferase activity (reviewed in Ghosh and Varga,
2007). The activity of STAT1 and STAT3 is known to be regulated
by EP300-dependent acetylation (Yuan et al., 2005; Hou et al.,
2008; Kotla and Rao, 2015; reviewed in Zhuang, 2013), and
complexes of EP300 and STAT3 can bind to the promoters
of IL6ST (Chen et al., 2008) and glial fibrillary acidic protein
(GFAP) (Nakashima et al., 1999) and regulate their expression. In
addition, inhibition of EP300 by C646 reduces phosphorylation
of STAT3 at tyrosine 705 by angiotensin II (Ni et al., 2014).
Tyrosine 705 phosphorylation induces STAT3 translocation to
the nucleus and activates its transcriptional activity (Wen et al.,
1995). Taken together with these reports, our findings support a
role for EP300 as a key modulator of the anti-apoptotic effects
of the endogenously activated STAT1/3–IL6ST/OSMR axis in
light-induced retinopathy.
Acetylation of STAT3 can be regulated not only by HATs
such as EP300 and CREB binding protein but also by HDACs
(reviewed in Choi and Reddy, 2011; Zhuang, 2013). Sirtuin
1, a member of the sirtuin family of HDACs, deacetylates
STAT3, resulting in decreased STAT3 tyrosine phosphorylation
and transcriptional activation (Nie et al., 2009). Excessive
HDAC activation plays a critical role in neurodegeneration in
a mouse model of retinitis pigmentosa (Sancho-Pelluz et al.,
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FIGURE 4 | Inhibition of EP300 increases retinal apoptosis in a larval zebrafish model of light-induced retinopathy. (A) Protocol for light-induced retinal
damage in larval zebrafish. Zebrafish are shielded from light between 3 and 5 days post-fertilization (dpf) and then exposed to normal conditions (14 h 250 lux/10 h
dark) or intense light (13,000 lux) in the presence or absence of 2µM C646 for 24 h at 27◦C. After light exposure, whole-mount TUNEL staining was performed. (B)
Representative images of TUNEL staining in the retina of zebrafish exposed to intense light (indicated as light+) or normal light conditions (light-). Scale bars, 100µm.
(C) Quantitative analysis of retinal apoptosis in zebrafish exposed to the conditions shown in (B). *p < 0.01, **p < 0.001, ***p < 0.0001. Data are the mean ± SEM of
13–14 zebrafish/group.
2010), and several HDAC inhibitors have neuroprotective effects
in retinal degenerative diseases (reviewed in Zhang et al.,
2015). Thus, activation of HATs and/or inhibition of HDACs
to increase STAT3 acetylation may be a potential therapeutic
approach for retinal degenerative diseases resembling light-
induced retinopathy.
EP300 Is Protective in a Larval Zebrafish
Model of Light-Induced Retinopathy
In this study, we demonstrated that inhibition of EP300 by C646
significantly increased (i) retinal apoptosis, (ii) photoreceptor
damage, and (iii) proliferation of putative Müller cells in a larval
zebrafish model of light-induced retinopathy.
Inhibition of photoreceptor apoptosis is an important
strategy to protect the morphology and function of the retina
in retinal degenerative diseases (Samardzija et al., 2006).
Application of ciliary neurotrophic factor (CNTF) and fibroblast
growth factor 2 (FGF2) to the retina significantly reduces
apoptosis (Kassen et al., 2009; Kolomeyer and Zarbin, 2014)
and increases the survival of photoreceptor cells in light-
induced retinopathy (reviewed in Organisciak and Vaughan,
2010). Moreover, the interaction between EP300 and STAT3 is
increased by treatment with CNTF (Hong and Song, 2014) or
FGF2 (Cheng et al., 2005), suggesting a possible mechanism
whereby CNTF and FGF2 reduce apoptosis and protect
photoreceptor cells from light-induced retinopathy. Further
studies are required to find small molecules that can activate
EP300 and to examine their effects on apoptosis in light-induced
retinopathy.
In this study, we described a new larval zebrafish model
of light-induced retinopathy. Although similar models have
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FIGURE 5 | Inhibition of EP300 reduces the photoreceptor cell outer segments in a zebrafish model of light-induced retinopathy. (A) Protocol for
light-induced retinal damage in larval zebrafish, as described for Figure 4A. After light exposure, whole-mount immunohistochemical staining with anti-Zpr3 antibody
was performed. (B) Representative images of anti-Zpr3 antibody staining of zebrafish exposed to normal or intense light. Scale bars, 100µm. (C) Quantitative analysis
of photoreceptor cell outer segments of zebrafish exposed to the conditions shown in (B). *p < 0.05. Data are the mean ± SEM of n = 24 zebrafish/group for
light−/C646- and light−/C646+, n = 17 for light+/C646−, and n = 22 for light+/C646+.
been successfully implemented with adult zebrafish (reviewed
in Gorsuch and Hyde, 2014), we are aware of only one
other report demonstrating that larval zebrafish can be used
to model light-induced retinopathy (Meyers et al., 2012). In
that study, larval zebrafish in a 50ml beaker were exposed to
light using a liquid fiber optic light line connected to a metal-
halide microscope illuminator. In our system, four multi-well
plates can be illuminated at the same time, allowing chemical
screening to be performed in a relatively high-throughput
manner.
The zebrafish and human retinas are very similar (reviewed
in Chhetri et al., 2014; Nishimura et al., 2015a). The neuronal
cell bodies in both zebrafish and humans are precisely organized
in three major laminae that are separated by plexiform
layers. Similar to humans, zebrafish are diurnal. Zebrafish
also have blood–brain and blood–retinal barriers (Watanabe
et al., 2012; Nishimura et al., 2013). There are a few
differences, however, between the visual systems of zebrafish
and humans; for example, zebrafish have lateral eyes with
reduced binocular overlap in the visual fields, less densely
populated ganglion cells, absent fovea, and tetrachromatic
vision (Chhetri et al., 2014). Understanding the similarities
and differences between zebrafish and human vision is critical
if the zebrafish model is to be useful for understanding the
pathophysiology of human retinal diseases and for developing
novel therapies. Many transgenic lines expressing fluorescent
proteins in specific retinal subpopulations have also been
developed and are available through public resources, enabling
various approaches to in vivo imaging of the retina of larval
zebrafish (Nishimura et al., 2015a). Knockout and knockin
of specific genes can also be performed using transcription
activator-like effector nuclease (TALEN) and clustered regularly
interspaced short palindromic repeats (CRISPR)-Cas9 systems
(Auer and Del Bene, 2014). When used in combination
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FIGURE 6 | Inhibition of EP300 increases BrdU incorporation in putative Müller cells in the zebrafish model of light-induced retinopathy. (A) Protocol for
light-induced retinal damage in larval zebrafish, as described for Figure 4A. After light exposure, whole-mount immunohistochemical staining with anti-BrdU antibody
was performed. (B) Representative images of anti-BrdU antibody staining of zebrafish exposed to normal or intense light. Scale bars, 100µm. (C) Quantitative
analysis of BrdU-positive cells in the retinas of zebrafish exposed to the conditions shown in (B). *p < 0.05. Data are the mean ± SEM of n = 8 for all groups.
with these advanced technologies, the larval zebrafish model
of light-induced retinopathy developed in this study will be
a powerful tool in the search for therapeutic compounds
that can protect photoreceptors from degenerative retinal
diseases.
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